Failure to legislate ‘will hurt research’

Even though stem cell manufacture has just been licensed in this country, the Government’s ongoing failure to legislate in this area means pharmaceutical giants will still be wary of investing here, according to an expert in stem cell therapy.

Failure to legislate ‘will hurt research’

The Irish Medicines Board has just licensed a new facility, the Centre for Cell Manufacturing Ireland, to supply adult stem cells for use in research on arthritis, heart disease, diabetes and other conditions.

Once the stem cells are harvested from the bone marrow of adult donors, they are grown in the Galway laboratory to generate sufficient quantities.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited